Evolution Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$431K Buy
359
+36
+11% +$36.8K 0.25% 71
2026
Q1
$297K Buy
323
+44
+16% +$44.6K 0.22% 78
2025
Q4
$300K Buy
279
+253
+973% +$242K 0.25% 76
2025
Q3
$19.8K Sell
26
-11
-30% -$8.19K 0.02% 301
2025
Q2
$28.8K Buy
+37
New +$28.8K 0.04% 238

Other funds holding LLY

Evolution Wealth Management's LLY Position: Q2 2026 in Review

Evolution Wealth Management increased its Eli Lilly (LLY) stake by 11% in Q2 2026, buying an estimated $36.8K and bringing the position to 359 shares worth $431K. The position accounts for 0.25% of the portfolio, ranked #71.

Evolution Wealth Management first reported a position in LLY in Q2 2025 and has held it in 5 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Evolution Wealth Management held 359 shares of Eli Lilly worth $431K as of Q2 2026.
  • Evolution Wealth Management bought 36 Eli Lilly shares in Q2 2026, an estimated $36.8K.
  • Eli Lilly made up 0.25% of Evolution Wealth Management's portfolio in Q2 2026, its #71 holding.
  • Evolution Wealth Management first reported a position in Eli Lilly in Q2 2025 and has held it in 5 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Evolution Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.